Skip to main content

Table 1 Baseline patients characteristics

From: Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

 

Number of case, median (range)

Age (years)

71 (48–86)

Gender (M/F)

52/63

Genotype (1b/2a,2b)

96/19

History of HCC (y/n)

29/86

Esophageal varices (n/y/unknown)

71/19/25

White blood cells (/µL)

3,850 (1,460–8,920)

Platelets (× 104/µL)

10.2 (3.2–24.1)

γ-GTP (U/L)

35 (13–388)

ALT (U/L)

46 (9–248)

Albumin (g/dL)

3.6 (1.6–4.3)

Total-bilirubin (mg/dL)

0.77 (0.2–1.9)

Creatinine (mg/dL)

0.70 (0.37–9.93)

Child–Pugh score

5 (5–8)

Fib-4 index

6.67 (1.85–25.39)

Splenic index (cm2)

36.5 (0*-80.0)

  1. M Male, F Female, n No, y Yes, HCC Hepatocellular carcinoma, γ-GTP γ -glutamyl transpeptidase, ALT Alanine amino transferase
  2. *splenectomy state